Abstract
Objective
To detect whether amlodipine could increase pre-ovulatory follicular blood flow, thus enhancing ovulation and creating a better chance of conception in women with PCOS.
Methods
165 women were screened of which 124 were qualified and women were equally randomized to 62 receiving clomiphene citrate and amlodipine and 62 receiving clomiphene citrate and placebo. The primary outcome was to detect if amlodipine can improve pre-ovulatory follicle blood flow studied by colour and power Doppler Pulsatility index of ovarian arteries, with drug administration. The secondary outcomes were endometrial thickness and clinical pregnancy.
Results
The mean value of the ovarian arteries Pulsatility Index was significantly lower in the amlodipine group when compared to those of the placebo group (1.36 and 1.82, respectively, with P value 0.002). Mean endometrial thickness, for all women in both groups, on the day of detecting a mature follicle was significantly higher in the amlodipine group compared to the placebo group (8.99 and 7.0, respectively, with P value 0.003), and clinical pregnancy increased from 11% to 37% in the amlodipine group compared to the placebo group.
Conclusion
Amlodipine improves ovarian blood flow and increases the chances of conception.
Trial registration
Pan African Clinical Trial Registry (http://www.pactr.org). Trial No: PAC TR201708002485292.
Similar content being viewed by others
Change history
08 August 2022
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s00404-022-06729-4
References
Adams J, Polson DW, Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J Clin Res Ed 293(6543):355–359
Panidisa D, Tziomalosb K, Papadakis E, Katsikis I (2013) Polycystic ovary syndrome. Novel insights into causesand therapy. Front Horm Res 40:128–141
Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF, Fitzpatrick LA (2003) Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88(6):2562–2568
Yildir IC, Kutluturk F, Tasliyurt T et al (2013) Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test. Gynecol Endocrinol 29(2):148–151
Dahlgren E, Janson PO, Johansson S, Lapidus L, Oden A (1992) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71(8):599–604
Lam P, Johnson I, Raine-Fenning N (2009) Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic. Ultrasound Obstet Gynecol 34:326–334
Ferreira A, Pires C, Moron A, Araujo JE, Traina E, Mattar R (2007) Doppler assessment of uterine blood flow in recurrent pregnancy loss. Int J Gynaecol Obstet 98:115–119
Cocksedge KA, Saravelos SH, Wang Q, Tuckerman E, Laird SM, Li TC (2008) Does free androgen index predict subsequent pregnancy outcome in women with recurrent miscarriage? Hum Reprod 23:797–802
Dolz M, Osborne NG, Javier Blanes J et al (1999) Polycystic ovarian syndrome: assessment with colour Doppler angiography and three-dimensional ultrasonography American Institute of Ultrasound in Medicine. J Ultrasound Med 18:303–313
Loverro G, Vicino M, Lorusso F, Vimercati A, Greco P, Selvaggi L (2001) Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow. Gynecol Endocrinol 15(2):142–149
Cameron I, Campbell S (1998) Nitric oxide in the endometrium. Hum Reprod Update 4:565–569
Ota H, Igarashi S, Hatazawa J, Tanaka T (1998) Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis an adenomyosis. Fertil Steril 69:303–308
Takasaki A, Tamura H, Miwa I, Taketani T, Shimamura K, Sugino N (2010) Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertil Steril 93(6):1851–1858
Jr Moreira SG, Brannigan RE, Spitz A, Francisco J, Orejuela FJ, Lipshultz LI, Kim ED (2000) Side-effect profile of sildenafil citrate (Viagra) in clinical practice. Urol J 56(3):474–476
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23:462–477
Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E (2009) Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane database. Syst Rev 4:CD002249
Johnson NP (2014) Metformin use in women with polycystic ovary syndrome. Ann Transl Med 2(6):56
The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47
Pfizer Canada Inc. Submission Control Number: 206420. http://www.pfizer.com. Accessed 12 Sept 2017
Calcium channel blocking drugs. https://dpic.org/sites/default/files/pdf/DIR_CCBs.pdf. Drug Information Reference ®2003
Official FDA information, www.drugs.com. International Labs Inc ® 2017
Zar JH (1984) Bio statistical analysis, 2nd edn. Prentice-Hall, Englewood Cliffs
Hintze J (2011) PASS 11 Kaysville, Utah, USA. www.ncss.com. NCSS, LLC
Fetih AN, Habib DM, Abdelaal II, Hussein M, Fetih GN, Othman E (2017) Adding sildenafil vaginal gel to clomiphene citrate in infertile women with prior clomiphene citrate failure due to thin endometrium: a prospective self-controlled clinical trial. Facts Views Vis Obgyn 9(1):21–27
Soliman GM, Fetih G, Abbas AM (2017) Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: in vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation. Drug Dev Ind Pharm 43(3):399–408. https://doi.org/10.1080/03639045.2016.1254239. (Epub 2016 Nov 14)
Sher G, Fisch JD (2000) Vaginal sildenafil (Viagra). A preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 15:806–809
Moretto MF, Lopez J, Negro-Vilar A (1993) Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 133:2399–2402
Moncada S, Higgs EA (1993) The l-arginine-nitric oxide pathway regulates luteinizing hormone-releasing hormone secretion. Endocrinol N Engl J Med 329:2002–2012
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nat Lond 327:524–526
Ledee-Bataille N, Olivennes F, Lefaix JL, Chaouat G, Frydman R, Delanian S (2002) Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod 17:1249–2125
(2017) Amlodipine pregnancy and breastfeeding warnings. http://www.drugs.com. Accessed 22 Aug 2017
Ahn HK, Nava-Ocampo AA, Han JY, Choi JS, Chung JH, Yang JH, Koong MK, Park CT (2007) Exposure to amlodipine in the first trimester of pregnancy and during breastfeeding. Hypertens Pregnancy 26(2):179–187
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340:c869
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors report that they neither have a conflict of interest nor received any financial support for this work.
Ethical approval
The study results are presented following the Consolidated Standards of Reporting Trials (CONSORT) criteria [33].
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1007/s00404-022-06729-4
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Torky, H.A., Shata, A., Ahmad, A.M. et al. RETRACTED ARTICLE: Effect of amlodipine on blood flow of preovulatory follicle in women with clomiphene resistant polycystic ovaries: a randomized controlled trial. Arch Gynecol Obstet 301, 845–850 (2020). https://doi.org/10.1007/s00404-020-05471-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-020-05471-z